輸入代號或公司名稱後按 Enter
CTSO

Cytosorbents Corp

+0.02 (+0.35%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 工業應用與服務 · Surgical & Medical Instruments & Apparatus
5.75USD2.4K成交股數361M市值本益比(近四季)9.7股價營收比+0.2%營收年增(近四季)2026-11-12下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營收9.6M+0%8.9M+2%9.2M+7%9.5M+7%9.6M+7%8.7M+1%8.6M-2%8.8M-6%9.0M8.7M8.8M9.4M
營業成本2.6M2.7M2.4M2.8M2.8M2.5M3.4M2.3M2.1M3.2M3.4M
毛利7.0M+3%6.1M-1%6.8M+29%6.7M+3%6.8M-1%6.2M+17%5.3M-6%6.5M+8%6.9M5.3M5.6M6.0M
毛利率73.2%69.2%73.7%70.3%70.9%71.1%61.0%73.5%76.5%61.3%63.6%63.9%
研發費用1.5M1.0M1.3M1.7M1.9M1.5M2.2M3.7M3.7M
銷售管理費用8.0M8.1M9.4M8.6M9.2M8.4M8.3M8.6M9.3M8.1M7.7M
營業利益−2.6M-27%−3.0M-22%−4.4M-9%−2.9M-20%−3.6M-22%−3.9M-59%−4.8M-34%−3.6M-46%−4.7M−9.4M−7.4M−6.6M
營業利益率-27.4%-34.3%-47.5%-30.2%-37.6%-44.6%-56.1%-40.4%-51.8%-108.5%-83.4%-69.6%
稅後淨利−4.4M-327%−5.1M+247%−5.5M+99%−3.2M-26%1.9M-132%−1.5M-75%−2.8M-70%−4.3M-30%−6.1M−5.8M−9.2M−6.2M
淨利率-45.9%-57.9%-59.5%-33.4%20.2%-16.9%-32.1%-48.6%-67.7%-67.3%-104.3%-65.3%
稀釋 EPS-0.07-333%-0.08+300%-0.09+80%-0.05-38%0.03-127%-0.02-83%-0.05-76%-0.08-47%-0.11-0.12-0.21-0.15
稀釋股數62.8M62.7M62.2M62.8M67.2M60.7M54.5M54.3M54.4M44.4M44.0M

資產負債表 期末餘額

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
現金與約當現金4.4M4.8M6.2M7.5M10.2M11.6M5.7M8.5M8.6M14.1M8.4M13.2M
應收帳款6.8M7.2M7.6M7.4M7.7M7.7M6.6M7.8M6.8M6.1M6.2M7.0M
存貨3.7M4.5M5.3M4.0M3.7M3.0M3.2M4.3M3.7M3.4M3.0M2.0M
總資產38.0M40.6M44.2M45.8M48.0M50.8M47.8M53.4M47.1M53.0M47.6M52.4M
有息負債3.1M10.3M16.7M14.6M14.4M14.2M13.8M13.7M1.9M2.5M4.2M5.0M
總負債38.7M38.4M38.3M36.7M36.4M36.2M34.7M36.0M27.4M29.5M28.8M28.0M
股東權益−751K2.2M5.9M9.0M11.6M14.5M13.4M17.4M19.6M23.5M18.8M24.5M
負債比102.0%94.6%86.6%80.3%75.9%71.4%72.5%67.4%58.3%55.7%60.5%53.4%
淨現金(現金 − 有息負債)1.3M−5.5M−10.4M−7.0M−4.2M−2.6M−8.1M−5.2M6.7M11.6M4.2M8.1M

現金流量表 單季

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營業現金流−1.2M-66%−3.5M−4.8M
資本支出11K2K45K
自由現金流−1.2M-66%−3.5M−4.9M
折舊攤銷369K397K
買回庫藏股
現金股利
自由現金流率-13.2%-39.7%-54.2%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 37.1M
Single Reportable37.1M100.0%+4.1%
主要客戶2025 年度 · 37.1M
Direct20.6M55.6%-0.9%
Distributors And Strategic Partners16.5M44.4%+11.1%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY202537.1M+4.1%−8.2M-22.1%-0.13−12.5M
FY202435.6M+14.5%−20.7M-58.2%-0.38−14.7M
FY202331.1M-10.4%−29.2M-94.1%-0.65−22.2M
FY202234.7M-19.6%−32.8M-94.6%-0.75−34.3M
FY202143.2M+5.3%−24.6M-56.9%-0.57−17.6M
FY202041.0M+64.4%−7.8M-19.1%-0.20−6.3M
FY201924.9M+10.9%−19.3M-77.2%-0.60−17.5M
FY201822.5M−17.2M-76.5%-0.56−11.5M